Skip to main content

Bejar Rafael's Form 4 filing

Aptose Biosciences Inc. (APTO) · filed Jul 1, 2026

Accession no.
0000912282-26-000893
Filed
Jul 1, 2026, 4:34 PM ET
Trade date
Jun 30, 2026
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 6 derivative transactions. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bejar RafaelCIK 0001797382Other: Former SVP&Ch Medical Officer

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 30, 2026Common SharesDReturned to the companyDisposed−244$1.72−$419.680Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 30, 2026Common SharesDReturned to the companyDisposed−35,000$0.00$00Direct
Jun 30, 2026Common SharesDReturned to the companyDisposed−200,000$0.00$00Direct
Jun 30, 2026Common SharesDReturned to the companyDisposed−400,000$0.00$00Direct
Jun 30, 2026Common SharesDReturned to the companyDisposed−343,000$0.00$00Direct
Jun 30, 2026Common SharesDReturned to the companyDisposed−200,000$0.00$00Direct
Jun 30, 2026Common SharesDReturned to the companyDisposed−400,000$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)